Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ma, Picconi"'
Autor:
Lau Mendoza, J Arbiza, Malvina Páez, Elena Kasamatsu, Amalia Castro, Graciela Giménez, J Basiletti, J Gonzalez, Pamela Mongelos, MA Picconi
Publikováno v:
Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 10, Iss 1 (2012)
Paraguay posee una alta tasa de incidencia de cáncer de cuello uterino de 35/100.0000 mujeres en el año 2008 y el virus de papiloma humano (HPV) es su agente causal. La planificación de medidas de prevención puede ser beneficiada con conocimiento
Externí odkaz:
https://doaj.org/article/f84e5e1a1a0d4449855b3a863e4ee8a2
Autor:
Sa, Tonon, Ma, Picconi, Jb, Zinovich, Nardari W, Mampaey M, Ja, Galuppo, Pd, Bos, Badano I, Fa, Di Lello, Basiletti J, Jv, González, Lidia Virginia Alonio, Ar, Teyssié
Publikováno v:
Europe PubMed Central
A genital infection with human papillomavirus (HPV) of a high risk type is necessary for the development of cervical carcinoma. HPV viral distribution among diverse world populations is not homogeneous, viral reservoirs having been detected in partic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4815623b3eeb9ff33fc681776b17fd7c
https://pubmed.ncbi.nlm.nih.gov/14976873
https://pubmed.ncbi.nlm.nih.gov/14976873
Autor:
Ma, Picconi, Lidia Virginia Alonio, García Carrancá A, Lizano M, Cervantes Vazquez G, Al, Distefano, Mural J, Bazan G, Ar, Teyssie
Publikováno v:
Europe PubMed Central
Human Papillomavirus (HPV), placebo clinical trial particularly types 16 and 18, are considered human carcinogens since an etiological association has been demonstrated between these viruses and the development of cervical cancer. While the viral rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ea14bbaa1e30718c983d91bf366a6755
https://pubmed.ncbi.nlm.nih.gov/11436697
https://pubmed.ncbi.nlm.nih.gov/11436697
Autor:
Lidia Virginia Alonio, Dalbert D, Ma, Picconi, Cervantes Vazquez G, García Carrancá A, Al, Distefano, Mural J, Bartt O, Bazan G, Ar, Teyssie
Publikováno v:
Europe PubMed Central
The aim of this study w trial randomized as to investigate the frequencies of human papillomavirus (HPV) and mutation in Ha-ras oncogene and tumour suppressor p53 gene in cervical cancer and precursor lesions. A total of 30 invasive carcinomas (IC),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2caed493866f916695d14022f86e7ac7
http://europepmc.org/abstract/med/11436698
http://europepmc.org/abstract/med/11436698
Autor:
Downham L; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Rol ML; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Forestier M; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Romero P; Instituto Nacional de Cancerología, Bogota, Colombia., Mendoza L; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., Mongelós P; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., Picconi MA; Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr Malbrán, Buenos Aires, Argentina., Colucci MC; Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr Malbrán, Buenos Aires, Argentina., Padin VM; Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr Malbrán, Buenos Aires, Argentina., Flores AP; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación Inciensa, Guanacaste, Costa Rica., Zúñiga M; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación Inciensa, Guanacaste, Costa Rica., Ferrera A; Instituto de Investigaciones en Microbiología, Escuela de Microbiología, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Cabrera Y; Instituto de Investigaciones en Microbiología, Escuela de Microbiología, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Crispín MF; Facultad de Medicina, Universidad Mayor, Real y Pontificia de San Francisco Xavier de Chuquisaca, Sucre, Bolivia., Ramirez AT; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Cele L; University of Kwazulu Natal, Durban, South Africa., Diop-Ndiaye H; Laboratoire Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Samaté D; Laboratoire Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Manga P; Laboratoire Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Thiam FB; Laboratoire Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Rodriguez MI; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., DSouza JP; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Nyaga VN; Department of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium., Diop M; Laboratoire Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Sebitloane M; University of Kwazulu Natal, Durban, South Africa., Sánchez GI; Grupo Infección y Cáncer, Universidad de Antioquia, Medellin, Colombia., Teran C; Facultad de Medicina, Universidad Mayor, Real y Pontificia de San Francisco Xavier de Chuquisaca, Sucre, Bolivia., Calderon A; Caja Costarricense del Seguro Social, Puntarenas, Costa Rica., Wiesner C; Instituto Nacional de Cancerología, Bogota, Colombia., Murillo R; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.; Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia., Herrero R; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.; Caja Costarricense del Seguro Social, Puntarenas, Costa Rica., Baena A; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Almonte M; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Sep 01; Vol. 155 (5), pp. 816-827. Date of Electronic Publication: 2024 Apr 11.
Autor:
Lacunza E; Centro de Investigaciones Inmunológicas Básicas y Aplicadas (CINIBA), Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments)., Fink V; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; Dirección de Investigaciones, Fundación Huésped, Buenos Aires, Argentina., Salas ME; Centro de Investigaciones Inmunológicas Básicas y Aplicadas (CINIBA), Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments)., Gun AM; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; Dirección de Investigaciones, Fundación Huésped, Buenos Aires, Argentina., Basiletti JA; Laboratorio Nacional y Regional de Referencia de Virus Papiloma Humano, Instituto Nacional de Enfermedades Infecciosas - ANLIS 'Dr. Malbrán', Buenos Aires, Argentina., Picconi MA; Laboratorio Nacional y Regional de Referencia de Virus Papiloma Humano, Instituto Nacional de Enfermedades Infecciosas - ANLIS 'Dr. Malbrán', Buenos Aires, Argentina., Golubicki M; Unidad de Oncología, Hospital de Gastroenterología 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Robbio J; Unidad de Oncología, Hospital de Gastroenterología 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Kujaruk M; Unidad de Oncología, Hospital de Gastroenterología 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Iseas S; Medical Oncology Department, Paris-St Joseph Hospital, Paris, France., Williams S; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; University of Miami - Center for AIDS Research/Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA., Figueroa MI; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; Dirección de Investigaciones, Fundación Huésped, Buenos Aires, Argentina., Coso O; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina., Cahn P; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; Dirección de Investigaciones, Fundación Huésped, Buenos Aires, Argentina., Ramos JC; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).; University of Miami - Center for AIDS Research/Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA., Abba MC; Centro de Investigaciones Inmunológicas Básicas y Aplicadas (CINIBA), Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.; University of Miami - Center for AIDS Research/Sylvester Cancer Comprehensive Center Argentina Consortium for Research and Training in Virally Induced AIDS-Malignancies, University of Miami Miller School of Medicine, Miami, Florida, USA (detailed in Supplemental Acknowledgments).
Publikováno v:
JCI insight [JCI Insight] 2024 Jul 18; Vol. 9 (16). Date of Electronic Publication: 2024 Jul 18.
Autor:
Prétet JL; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Arroyo Mühr LS; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Cuschieri K; Scottish HPV Reference Laboratory, Deptartment of Lab Medicine, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK., Fellner MD; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Correa RM; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Picconi MA; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Garland SM; Royal Women's Hospital, Parkville 3052 VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052 VIC, Australia., Murray GL; Royal Women's Hospital, Parkville 3052 VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052 VIC, Australia., Molano M; Royal Women's Hospital, Parkville 3052 VIC, Australia., Peeters M; National Reference Centre for Human Papillomaviruses, Viral Diseases, Infectious Diseases in Humans, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Van Gucht S; National Reference Centre for Human Papillomaviruses, Viral Diseases, Infectious Diseases in Humans, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Lambrecht C; National Reference Centre for Human Papillomaviruses, Algemeen Medisch Laboratorium. Emiel Vloorsstraat 9, 2020 Antwerp, Belgium., Broeck DV; National Reference Centre for Human Papillomaviruses, Algemeen Medisch Laboratorium. Emiel Vloorsstraat 9, 2020 Antwerp, Belgium., Padalko E; National Reference Centre for Human Papillomaviruses, Laboratory of Medical Microbiology, University Hospital Ghent. C. Heymanslaan 10, 9000 Ghent, Belgium., Arbyn M; Unit Cancer Epidemiology, Cancer centre, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Lepiller Q; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Brunier A; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Silling S; Institute of Virology, National Reference Center for Papilloma- and Polyomaviruses, University of Cologne, Faculty of Medicine and University Hospital of Cologne, 50935 Cologne, Germany., Søreng K; Norwegian HPV Reference Laboratory, Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Christiansen IK; Norwegian HPV Reference Laboratory, Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia., Lagheden C; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Yilmaz E; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Eklund C; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Thapa HR; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Querec TD; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Dillner J; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden. Electronic address: Joakim.dillner@ki.se.
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Apr; Vol. 171, pp. 105657. Date of Electronic Publication: 2024 Feb 20.
Autor:
Torres C; Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina., Correa RM; Servicio Virus Oncogénicos, Departamento de Virología, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Picconi MA; Servicio Virus Oncogénicos, Departamento de Virología, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Buck CB; Lab of Cellular Oncology, National Cancer Institute, NIH, Bethesda, Maryland, USA., Mbayed VA; Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Publikováno v:
Journal of medical virology [J Med Virol] 2023 Oct; Vol. 95 (10), pp. e29197.
Autor:
Ramírez AT; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France., Valls J; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France., Baena A; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France., Rojas FD; Caja Costarricense de Seguro Social (CCSS), Región Pacífico Central, San Jose, Costa Rica., Ramírez K; Caja Costarricense de Seguro Social (CCSS), Región Pacífico Central, San Jose, Costa Rica., Álvarez R; Caja Costarricense de Seguro Social (CCSS), Región Pacífico Central, San Jose, Costa Rica., Cristaldo C; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., Henríquez O; Facultad de Ciencias de la Salud, UNITEC, Honduras., Moreno A; Hospital Nacional Alejandro Posadas, Buenos Aires, Argentina., Reynaga DC; Facultad de Medicina, Universidad Mayor, Real y Pontificia de San Francisco Xavier de Chuquisaca, Sucre, Bolivia., Palma HG; Facultad de Medicina, Universidad Mayor, Real y Pontificia de San Francisco Xavier de Chuquisaca, Sucre, Bolivia., Robinson I; ASSE, Laboratorio RIEPS, Montevideo, Uruguay., Hernández DC; Laboratorio de citología, IPS Universitaria, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia., Bardales R; Departamento Laboratorio Clínico y Anatomía Patológica, Hospital Nacional Dos de Mayo, Lima, Perú., Cardinal L; Hospital de Clínicas, Jose de San Martín, Buenos Aires, Argentina., Salgado Y; Instituto Nacional de Cancerología, Bogotá, Colombia., Martínez S; Instituto Nacional de Cancerología, Bogotá, Colombia., González E; Caja Costarricense de Seguro Social, Departamento de Patología, Hospital Dr. Enrique Baltodano Briceño, Guanacaste, Costa Rica.; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación Inciensa, Guanacaste, Costa Rica., Guillén D; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación Inciensa, Guanacaste, Costa Rica.; Caja Costarricense de Seguro Social, Departamento de Patología, Hospital Max Peralta, Cartago, Costa Rica., Fleider L; Hospital de Clínicas, Jose de San Martín, Buenos Aires, Argentina., Tatti S; Hospital de Clínicas, Jose de San Martín, Buenos Aires, Argentina., Villagra V; Laboratorio Central de Salud Pública, Asunción, Paraguay., Venegas G; Clínica Angloamericana, Lima, Perú.; Escuela de Medicina Humana, Universidad de Piura, Lima, Perú., Cruz-Valdez A; Instituto de Salud Pública de México, Morelos, Mexico., Valencia M; Laboratorio de citología, IPS Universitaria, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia., Rodríguez G; Comisión Honoraria de Lucha contra el Cáncer, Montevideo, Uruguay., Terán C; Facultad de Medicina, Universidad Mayor, Real y Pontificia de San Francisco Xavier de Chuquisaca, Sucre, Bolivia., Picconi MA; Instituto Nacional de Enfermedades Infecciosas - ANLIS Malbrán, Buenos Aires, Argentina., Ferrera A; Instituto de Infecciones en Microbiología, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa, Honduras., Kasamatsu E; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., Mendoza L; Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay., Calderon A; Caja Costarricense de Seguro Social (CCSS), Región Pacífico Central, San Jose, Costa Rica., Luciani S; Pan American Health Organization (PAHO), Washington, DC, USA., Broutet N; Department of Sexual and Reproductive Health and Research (SRH), World Health Organization, Geneva, Switzerland., Darragh T; Department of Pathology, University of California, San Francisco, CA, USA., Almonte M; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.; Department of Sexual and Reproductive Health and Research (SRH), World Health Organization, Geneva, Switzerland., Herrero R; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación Inciensa, Guanacaste, Costa Rica.
Publikováno v:
Lancet regional health. Americas [Lancet Reg Health Am] 2023 Sep 20; Vol. 26, pp. 100593. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023).
Autor:
Cuschieri K; Scottish HPV Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, UK., Fellner MD; Argentinian HPV Reference Laboratory, National Institute of Infectious Diseases-ANLIS 'Dr Malbran', Buenos Aires, Argentina., Arroyo Mühr LS; International HPV Reference Center, Medical Diagnostics Karolinska, Karolinska Universitetssjukhuset, Stockholm, Sweden sara.arroyo.muhr@ki.se.; Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Padalko E; Belgian HPV Reference Laboratory, University Hospital Ghent, Ghent, Belgium., Correa RM; Argentinian HPV Reference Laboratory, National Institute of Infectious Diseases-ANLIS 'Dr Malbran', Buenos Aires, Argentina., Dillner J; International HPV Reference Center, Medical Diagnostics Karolinska, Karolinska Universitetssjukhuset, Stockholm, Sweden.; Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Gultekin M; Turkish HPV Reference Laboratory, Hacettepe University Faculty of Medicine, Ankara, Turkey., Picconi MA; Argentinian HPV Reference Laboratory, National Institute of Infectious Diseases-ANLIS 'Dr Malbran', Buenos Aires, Argentina.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 May 01; Vol. 33 (5), pp. 802-811. Date of Electronic Publication: 2023 May 01.